Furthermore, PKCθ enhances glycolysis and upregulates PD‐L1 expression by regulating tumor cell metabolism, which inhibits effector T cell function and leads to a vicious cycle of metabolic‐immune suppression in tumor types such as lung cancer [256]. This evidence concerns the gene PRRT2 and neoplasm.